Review of the scientific literature on drivers and barriers of seasonal influenza vaccination coverage in the EU/EEA
The report aims to provide a critical review of evidence on the barriers and drivers of seasonal influenza vaccination coverage in the EU/EEA. The report focuses on high-risk groups where high coverage of seasonal flu vaccination is most important. The 2009 Council of the European Union Recommendation on seasonal influenza vaccination encourages countries to implement measures that would increase seasonal influenza vaccination uptake to at least 75% for defined older age groups, and, if possible, for other risk groups. In support of this, the ECDC report summarises the evidence on what are the barriers and what are the drivers for seasonal influenza vaccination by each risk group
Expert opinion on priority risk groups for influenza vaccination
This paper identifies and describes population groups at increased risk for severe outcomes of influenza (“risk groups”) and advocates vaccination for two major groups, namely a) persons in the older age group, usually 65 years and older; and b) persons with chronic medical conditions.
Interim technical guidance on public health use of influenza antivirals during influenza pandemics
Antiviral drugs are an important addition to the public health arsenal against influenza. This interim guidance discusses the options for their effective use, especially during a pandemic.
Interim technical guidance on use of specific pandemic influenza vaccines during the H1N1 2009 pandemic
This interim guidance outlines the possible strategies that countries may wish to adopt in the deployment of a pandemic-specific vaccine, considering the two objectives of vaccination: protecting those at greatest risk of severe disease and maintaining essential services.
Assessing vaccination coverage in the European Union: is it still a challenge?Archived
The authors review some of the different systems that are used for assessing vaccination coverage within and outside the EU in order to explore the need for improving vaccination coverage data quality.
Rubella revisited: Where are we on the road to disease elimination in Central Europe?Archived
Elimination of rubella and prevention of congenital rubella infection in Europe has been a high priority for the WHO European Regional Office over the past decade. In 2010 the WHO regional committee for Europe renewed its commitment to the elimination of rubella and prevention of CRS with a new target of 2015. For Central Europe to reach the target of rubella elimination and prevention of CRS by 2015, very high vaccine coverage levels need to be maintained and catch-up campaigns continued to address susceptible groups, in particular women of child-bearing age.
Global estimates of the direct burden of influenza on the health of younger children (under age 5 years) including separate estimates for the European RegionArchived
It is accompanied by an editorial comment from Maria Zambon of the UK Health Protection Agency add link pleaseThis comprehensive study published by an international group attempts to estimate the global incidence of lower respiratory infections and premature deaths associated with influenza in children younger than 5 years.
Decline in early childhood respiratory tract infections in the norwegian mother and child cohort study after introduction of pneumococcal conjugate vaccinationArchived
The study design and analysis controlled for influence of potentially confounding trends, such as improvement of day-care carriage and decreasing prevalence of smoking during the study period.
ECDC Director speaks on reinforcing trust, key role of doctors, healthcare workers to reach EU vaccination goalsArchived
The role of doctors and healthcare workers in direct contact with parents and children is paramount," said ECDC Director Dr. Marc Sprenger at the World Health Summit in Berlin, Germany.